1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Top Countries

  • All
    • United States
About 3600 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Lymphoma Drugs Market 2017-2021

  • $ 2500
  • June 2017
  • 86 pages

The aim of lymphoma treatment is to get rid of the lymphoma cells.

  • Lymphoma
  • United States
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030 ##.

  • Cancer
  • Lung Cancer
  • Lymphoma
  • Pathology
  • United States

Anaplastic lymphoma kinase Non-Small Cell Lung Cancer (ALK-NSCLC)-Market Insights, Epidemiology and Market Forecast to 2030

  • $ 4750
  • May 2020
  • 200 pages

Anaplastic lymphoma kinase Non-Small Cell Lung Cancer Drug Chapters Drug chapter segment of the Anaplastic lymphoma kinase Non-Small Cell Lung Cancer report encloses the detailed analysis of Anaplastic lymphoma kinase Non-Small Cell Lung Cancer marketed drugs and late stag

  • Cancer
  • Lung Cancer
  • Lymphoma
  • Pathology
  • United States

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026

  • $ 22000
  • January 2019
  • 510 pages

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026 CONTENTS ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## January 2019) ## OVERVIEW ## RECENT FORECAST UPDATES ## MARKET DYNAMICS ## FORECAST AND FUTURE TRENDS ## MARKET DEFINITION AND METHODOLOGY ## PRIMARY

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034, Pharma Intelligence

  • $ 22000
  • October 2018
  • 475 pages

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034, Pharma Intelligence Table of Contents (Forecast, Treatment, Epidemiology Datapacks included) ## FORECAST: DIFFUSE LARGE B-CELL LYMPHOMA (Published on ## October 2018) ## OVERVIEW ## RECENT FORECAST UPDATES

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

  • $ 22000
  • April 2018
  • 229 pages

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025 TABLE OF CONTENTS Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## METHODOLOGY

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034

  • $ 22000
  • April 2018
  • 196 pages

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034 TABLE OF CONTENTS & nbsp; (Forecast, Treatment and Epidemiology Datapacks included) & nbsp; ## FORECAST: MANTLE CELL LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034

  • $ 22000
  • April 2018
  • 162 pages

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034 TABLE OF CONTENTS & nbsp; (Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: DIFFUSE LARGE B-CELL LYMPHOMA (Published on ## August 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVE

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

Vaginal Cancer - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 381 pages

It is in Phase I stage of development for diffuse large B cell lymphoma and high-grade B cell lymphoma.

  • Lung Cancer
  • Lymphoma
  • Sexually Transmitted Disease
  • North America
  • United States

Umbilical Cord Blood Banking Market Research Report by Storage, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 3949
  • July 2020
  • 230 pages

Lymphoma ##. ##.

  • Lymphoma
  • Medical Biotechnology
  • United States
  • World
  • Market Size

Oral Cancer Treatment Market Research Report by Product Type, by Treatment, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 3949
  • July 2020
  • 231 pages

Lymphomas ##. ##.

  • Cancer
  • Lymphoma
  • Oropharynx Cancer
  • United States
  • Market Size

Global Veterinary Oncology Market By Animal Type By Therapy By Cancer Type By Region, Industry Analysis and Forecast, 2020 - 2026

  • $ 3600
  • April 2020
  • 209 pages

Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others.

  • Lymphoma
  • Oncology
  • Therapy
  • United States
  • Market Size

Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026

  • $ 4000
  • February 2020
  • 600 pages

Lymphoma Treatment (Week), January’2020 Figure ##-##: Gazyva – Minimum & Maximum Treatment Cost of Follicular Lymphoma (US$), January’2020 Figure ##-##: Gazyva – Duration of Single Treatment Cycle & Full Treatment Using Monotherapy (Months), January’2020 Figure ##-##: Gazyv

  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • United States
  • Supply

Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026

  • $ 2800
  • April 2019
  • 1200 pages

Lymphomas (US$), July 2018 Figure ##-##: US – Yescarta Target Dose vs Maximum Dose of CAR-positive viable T cells, October 2017 Figure ##-##: US - Yescarta & Kymriah Overall Treatment Cost (US$), April 2018 Figure ##-##: US - Yescarta & Kymriah Estimated Payment Rate by Centers for Medic

  • Cell Therapy
  • Lymphoma
  • Medical Biotechnology
  • United States
  • World

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020

  • $ 3495
  • April 2020
  • 400 pages

Lymphoma Society, LifeLink Foundation, LifeLiver, LifeQ, LineaRx, Lipidor, LogicNets, Loreal, Louisiana State University, Loxo Oncology, Lupin Limited, Luye Pharma Group, Macrogen, MAKScientific, Mallinckrodt Pharmaceuticals, Marina Biotech, Marshall Institute for Interdisciplinary Research

  • Biotechnology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Betalutin

  • $ 10000
  • January 2019
  • 17 pages

CD## is highly expressed in B cells and B-cell lymphomas.

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

Aliqopa

  • $ 10000
  • January 2019
  • 18 pages

Aliqopa CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Aliqopa : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: Aliqopa for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Aliqopa for follicular

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • United States

INCB050465

  • $ 10000
  • January 2019
  • 16 pages

INCB## CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## INCB## : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: INCB## for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of INCB## for folli

  • Cancer
  • Lymphoma
  • Pathology
  • United States
  • Forecast

umbralisib

  • $ 10000
  • January 2019
  • 26 pages

umbralisib CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## umbralisib : NHL: Follicular lymphoma (FL) ## umbralisib : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Umbralisib for follicular lymphoma – SWOT analysis ## Figure ##: Datamo

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States
View report >

Lymphoma Statistics

  • December 2019
  • 11 pages

Survival of patients with Burkitt lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on